BEACON Pharmaceutical Ltd (BEAC)

Currency in BDT
108.20
-1.50(-1.37%)
Closed·
BEAC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
107.80110.20
52 wk Range
96.00147.50
Key Statistics
Prev. Close
124.3
Open
109.8
Day's Range
107.8-110.2
52 wk Range
96-147.5
Volume
194.43K
Average Volume (3m)
393.05K
1-Year Change
-8.3051%
Book Value / Share
33.55
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BEAC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Earnings

Latest Release
Jun 01, 2026
EPS / Forecast
1.22 / --
Revenue / Forecast
3.8B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.31%
Dividend Yield
1.69%
Industry Median 4.03%
Annualized payout
2.10
Paid annually
5-Years Growth
+31.95%
Growth Streak

BEAC Income Statement

Compare BEAC to Peers and Sector

Metrics to compare
BEAC
Peers
Sector
Relationship
P/E Ratio
17.2x7.6x−0.3x
PEG Ratio
0.23−1.290.00
Price/Book
3.2x1.5x2.6x
Price / LTM Sales
1.6x3.1x2.9x
Upside (Analyst Target)
-29.7%57.8%
Fair Value Upside
Unlock2.0%9.5%Unlock

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories such as oncology, hematology, anti-cancer, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestinal, infectious diseases, immunology, rheumatology, muscle relaxants, antihistamines, anti-coagulants, protein supplements, pediatrics, NSAIDs, nutritional supplements, and others. In addition, the company offers contract and toll manufacturing services. It provides its products under the Pemro, Nivomab, Xelpac Premium, Docexan, Xaloplat Aqua, Gemoxen Aqua, ETP, FXR, Renesis, Mezest, Eposis, Tirza, Xelmet, Xerova, Sinjard, Ovocal, Haxinor, Tetrazin, Lubilux, Paloxi, Olonex, Gaviflux, Mirogab, Flexibac, and Bukof brand name. Beacon Pharmaceuticals PLC was incorporated in 2001 and is based in Dhaka, Bangladesh.

Employees
4771

FAQ

What Is the BEACON Pharma (BEAC) Stock Price Today?

The BEACON Pharma stock price today is 108.20 BDT.

What Stock Exchange Does BEACON Pharma Trade On?

BEACON Pharma is listed and trades on the Dhaka Stock Exchange.

What Is the Stock Symbol for BEACON Pharma?

The stock symbol for BEACON Pharma is "BEAC."

Does BEACON Pharma Pay Dividends? What’s The Current Dividend Yield?

The BEACON Pharma dividend yield is 1.95%.

What Is the BEACON Pharma Market Cap?

As of today, BEACON Pharma market cap is 24.99B BDT.

What Is BEACON Pharma's Earnings Per Share (TTM)?

The BEACON Pharma EPS (TTM) is 6.31.

From a Technical Analysis Perspective, Is BEAC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BEACON Pharma Stock Split?

BEACON Pharma has split 1 times.

How Many Employees Does BEACON Pharma Have?

BEACON Pharma has 4771 employees.

What is the current trading status of BEACON Pharma (BEAC)?

As of Jul 26, 2026, BEACON Pharma (BEAC) is trading at a price of 108.20 BDT, with a previous close of 124.30 BDT. The stock has fluctuated within a day range of 107.80 BDT to 110.20 BDT, while its 52-week range spans from 96.00 BDT to 147.50 BDT.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.